Salvicine, a novel topoisomerase II inhibitor, exerts its potent anticancer activity by ROS generation. [electronic resource]
- Acta pharmacologica Sinica Sep 2007
- 1460-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1671-4083
10.1111/j.1745-7254.2007.00698.x doi
Animals Antineoplastic Agents, Phytogenic--pharmacology DNA Damage--drug effects DNA Topoisomerases, Type II--metabolism Humans Naphthoquinones--pharmacology Reactive Oxygen Species--metabolism Topoisomerase II Inhibitors